James R Stark insider trades: Bio-Rad Laboratories (BIO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 11, 2019 | BIO | ↓ Sell | 848 | $351.45 | $298K | Direct | Nov 12, 2019 (1d) |
| Dec 12, 2018 | BIO | ↓ Sell | 848 | $254.77 | $216K | Direct | Dec 12, 2018 (0d) |
| Nov 30, 2017 | BIO | ↓ Sell | 746 | $270.51 | $202K | Direct | Nov 30, 2017 (0d) |
| Nov 9, 2016 | BIO | ↓ Sell | 1,299 | $171.42 | $223K | Direct | Nov 9, 2016 (0d) |
| Nov 7, 2016 | BIO | ↓ Sell | 76 | $165.62 | $13K | Direct | Nov 8, 2016 (1d) |
| Sep 13, 2016 | BIO | ↓ Sell | 76 | $158.09 | $12K | Direct | Sep 14, 2016 (1d) |
| Sep 12, 2016 | BIO | ↓ Sell | 269 | $155.02 | $42K | Direct | Sep 13, 2016 (1d) |
| Sep 14, 2015 | BIO | ↓ Sell | 152 | $139.11 | $21K | Direct | Sep 15, 2015 (1d) |
| Sep 11, 2015 | BIO | ↓ Sell | 76 | $137.50 | $10K | Direct | Sep 14, 2015 (3d) |
| Sep 9, 2015 | BIO | ↓ Sell | 76 | $139.01 | $11K | Direct | Sep 10, 2015 (1d) |
| Nov 11, 2014 | BIO | ↓ Sell | 4,257 | $112.60 | $479K | Direct | Nov 12, 2014 (1d) |
| Sep 10, 2012 | BIO | ↓ Sell | 77 | $103.49 | $8K | Direct | Sep 11, 2012 (1d) |
| Jun 12, 2012 | BIO | ↓ Sell | 74 | $96.51 | $7K | Direct | Jun 13, 2012 (1d) |
| Jun 11, 2012 | BIO | ↓ Sell | 74 | $96.49 | $7K | Direct | Jun 12, 2012 (1d) |
| Sep 9, 2011 | BIO | ↓ Sell | 75 | $94.85 | $7K | Direct | Sep 12, 2011 (3d) |
| Jun 14, 2011 | BIO | ↓ Sell | 75 | $117.53 | $9K | Direct | Jun 15, 2011 (1d) |
| Jun 13, 2011 | BIO | ↓ Sell | 74 | $117.30 | $9K | Direct | Jun 14, 2011 (1d) |
| Mar 7, 2011 | BIO | ↓ Sell | 5,000 | $114.23 | $571K | Direct | Mar 7, 2011 (0d) |
| Aug 4, 2009 | BIO | ↓ Sell10b5-1 | 74 | $76.01 | $6K | Direct | Aug 4, 2009 (0d) |
| Jun 12, 2009 | BIO | ↓ Sell10b5-1 | 73 | $74.80 | $5K | Direct | Jun 16, 2009 (4d) |
| Aug 21, 2008 | BIO | ↓ Sell | 7,500 | $100.50 | $754K | Direct | Aug 22, 2008 (1d) |
| Aug 4, 2008 | BIO | ↓ Sell10b5-1 | 74 | $89.02 | $7K | Direct | Aug 6, 2008 (2d) |
| Jun 8, 2007 | BIO | ↓ Sell | 5,790 | $73.99 | $428K | Direct | Jun 12, 2007 (4d) |
| Mar 8, 2006 | BIO | ↓ Sell | 9,500 | $59.25 | $563K | Direct | Mar 9, 2006 (1d) |
| May 13, 2005 | BIO | ↓ Sell | 5,210 | $52.13 | $272K | Direct | May 17, 2005 (4d) |
| Nov 30, 2004 | BIO | ↓ Sell | 400 | $56.90 | $23K | Direct | Aug 3, 2007 (976d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James R Stark's insider trades
James R Stark is VP, Corporate Controller at Bio-Rad Laboratories (BIO). Since Nov 30, 2004, James has reported no open-market purchases and 26 sales worth $4.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
3 sales (0% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (35 filings), shares withheld for taxes (15 filings), grants and awards (14 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.